Примери за използване на Patients were male на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Of patients were male.
Fewer than 5% of patients were male.
Most patients were male(58%) and white(92%).
A total of 53.0% of patients were male.
Most patients were male(81%), and the majority of patients were White(91%).
Approximately 58% of patients were male.
Age of the overall study population ranged from 20 to 66 years old and about 2/3 of the patients were male.
Of the patients were male;
In the overall population, 72.7% of the patients were male.
The majority of the patients were male(59%) and white(90%).
The median age was 63 years(range: 31 to 90),and 60% of patients were male.
The majority of patients were male(57%); 8% had mBCC whereas 92% had laBCC.
Fifty seven percent of patients were male.
The majority of patients were male(59%) and white(79%); the median age for the overall population was 64 years(min, max: 35, 87 years).
Approximately 62% of the patients were male.
The majority of patients were male(65%), white(80%), and 9% had brain metastases and most patients were current or previous smokers(97%).
The median age was 67 years(range: 31 to 88),and 77.1% of patients were male.
The majority of the patients were male(78%) with a median age of 62 years.
The mean age was 63 years(range 33 to 89 years)and 80% of patients were male.
Sixty percent of patients were male and 99.6% were Caucasian;
The median patient age at baseline was 62(range, 24 to 83) years and 74% of patients were male, 26% were female.
Approximately half of the patients were male, and the mean age was 77.4 years.
Most patients were male(56%) and Caucasian(99%), the median agewas 54 years(24% were≥ 65 years), all patients had ECOG performance status of 0 or 1, and the majority of patients had stage M1c disease(65%).
In the total population, 57.3% of patients were male and 93.2% were Caucasian.
The majority of patients were male(61.6%), and Caucasian(92.5%), and the median age was 54 years(range 26 to 83 years), similarly distributed between the two cohorts.
The mean age was 50 years(range 28-67), 92% of patients were male, 69% were White, 18% were Black, and 10% were Asian.
Of patients were male, median age was 55 years(range 23 to 88 years), 60% had metastatic melanoma stage M1c and the proportion of patients with elevated LDH was 46.3% in the cobimetinib plus vemurafenib arm and 43.0% in the placebo plus vemurafenib arm.
The median age was 56 years(range: 23 to 77);74% of patients were male; 97% were white; 63% had genotype 1a HCV infection; 94% had non-CC IL28B alleles(CT or TT).
About two-thirds of the patients were male and approximately one-third had a baseline ECOG performance status(PS) of 2, and 9% had a baseline ECOG PS of 3.
The median age was 67 years(range 36 to 81); 62% of patients were older than 65 years;57% of patients were male; whites comprised 77% of the study population, Asians 21%, and blacks 1%.